Cargando…
Human SLFN5 is a Transcriptional Co-repressor of STAT1-Mediated Interferon Responses and Promotes the Malignant Phenotype in Glioblastoma
We provide evidence that the IFN-regulated member of the Schlafen (SLFN) family of proteins, SLFN5, promotes the malignant phenotype in glioblastoma multiforme (GBM). Our studies indicate that SLFN5 expression promotes motility and invasiveness of GBM cells, and that high levels of SLFN5 expression...
Autores principales: | Arslan, Ahmet Dirim, Sassano, Antonella, Saleiro, Diana, Lisowski, Pawel, Kosciuczuk, Ewa M., Fischietti, Mariafausta, Eckerdt, Frank, Fish, Eleanor N., Platanias, Leonidas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821504/ https://www.ncbi.nlm.nih.gov/pubmed/28671669 http://dx.doi.org/10.1038/onc.2017.205 |
Ejemplares similares
-
PB1791: SLFN11 REGULATES MULTIPLE PATHWAYS THAT ARE IMPORTANT FOR TREATMENT RESPONSE IN AML
por: Small, Sara, et al.
Publicado: (2023) -
SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
por: Fischietti, Mariafausta, et al.
Publicado: (2022) -
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells
por: Saleiro, Diana, et al.
Publicado: (2023) -
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms
por: Saleiro, Diana, et al.
Publicado: (2022) -
Schlafen 5 as a Novel Therapeutic Target in Pancreatic Ductal Adenocarcinoma
por: Fischietti, Mariafausta, et al.
Publicado: (2021)